Want to see DH full AI Analyst Report?
DH Stock Chart & Stats
$1.03
-$0.06(-1.41%)
At close: 4:00 PM EST
$1.03
-$0.06(-1.41%)
Day’s Range― - ―
52-Week Range$0.62 - $4.70
Previous CloseN/A
Volume69.97K
Average Volume (3M)338.90K
Market Cap
$98.18M
Enterprise Value$164.96
Total Cash (Recent Filing)$178.09M
Total Debt (Recent Filing)$169.84M
Price to Earnings (P/E)―
Beta1.76
Next Earnings
Aug 12, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.62
Shares Outstanding105,524,240
10 Day Avg. Volume311,870
30 Day Avg. Volume338,897
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)1.09
Price to Sales (P/S)1.27
P/FCF Ratio8.26
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$1.45Price Target Upside40.78% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering6
EPS Forecast (FY)0.18
Revenue Forecast (FY)$223.43M
Bulls Say, Bears Say
Bulls Say
High Gross MarginsSustained gross margins near ~80% reflect strong unit economics from proprietary, curated healthcare datasets. High gross margins create durable operating leverage: they allow investment in product, AI and integrations while supporting adjusted profitability as sales scale or recover.
Strong Free Cash FlowMeaningful positive free cash flow provides durable funding for product development, integrations and working capital without reliance on external financing. FCF cushions execution risk while management pursues margin expansion and monetization initiatives tied to long-term product roadmap.
Improved Retention & Faster IntegrationsBetter retention, frequent win-backs and materially faster integrations increase customer stickiness and shorten sales cycles. These structural improvements support higher lifetime value and cross-sell of data, digital activation and services over months to years, aiding sustainable revenue recovery.
Bears Say
Revenue ContractionPersistent top-line declines signal demand weakness in key end markets (life sciences) and reduce operating leverage. Continued revenue contraction over multiple quarters makes it harder to convert high gross margins into GAAP profitability and risks erosion of scale advantages.
Ongoing GAAP LossesSustained operating and net losses erode equity and limit financial flexibility over time. Even with adjusted profitability, prolonged GAAP deficits raise the risk of future impairments, constrain strategic investments, and could necessitate capital raises if cash generation weakens.
Declining Deferred Revenue & Shorter ContractsFalling deferred revenue and a shift to single-year deals reduce revenue visibility and lifetime value. Shorter contract durations make forecasting and upsell harder, weaken predictable recurring revenue streams, and increase sensitivity to churn and renewals over the medium term.
Definitive Healthcare Corp News
DH FAQ
What was Definitive Healthcare Corp’s price range in the past 12 months?
Definitive Healthcare Corp lowest stock price was $0.62 and its highest was $4.70 in the past 12 months.
What is Definitive Healthcare Corp’s market cap?
Definitive Healthcare Corp’s market cap is $98.18M.
When is Definitive Healthcare Corp’s upcoming earnings report date?
Definitive Healthcare Corp’s upcoming earnings report date is Aug 12, 2026 which is in 18 days.
How were Definitive Healthcare Corp’s earnings last quarter?
Definitive Healthcare Corp released its earnings results on May 07, 2026. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.033 by $0.027.
Is Definitive Healthcare Corp overvalued?
According to Wall Street analysts Definitive Healthcare Corp’s price is currently Undervalued.
Does Definitive Healthcare Corp pay dividends?
Definitive Healthcare Corp does not currently pay dividends.
What is Definitive Healthcare Corp’s EPS estimate?
Definitive Healthcare Corp’s EPS estimate is 0.04.
How many shares outstanding does Definitive Healthcare Corp have?
Definitive Healthcare Corp has 105,524,240 shares outstanding.
What happened to Definitive Healthcare Corp’s price movement after its last earnings report?
Definitive Healthcare Corp reported an EPS of $0.06 in its last earnings report, beating expectations of $0.033. Following the earnings report the stock price went up 3.254%.
Which hedge fund is a major shareholder of Definitive Healthcare Corp?
Currently, no hedge funds are holding shares in DH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Definitive Healthcare Corp Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$1.45 (40.78% Upside)
$1.45 (40.78% Upside)
Hedge Fund Trend
Decreased
By 85.7K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.79%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-36.35%
Trailing 12-Months
Company Description
Definitive Healthcare Corp
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
DH Stock 12 Month Forecast
Average Price Target
$1.45
▲(40.78% Upside)
Technical Analysis
Ownership Overview
12.12% Insiders
3.86% Mutual Funds
0.27% Other Institutional Investors
79.47% Public Companies and
Individual Investors